LORATADINE REDIDOSE Drug Patent Profile
✉ Email this page to a colleague
When do Loratadine Redidose patents expire, and what generic alternatives are available?
Loratadine Redidose is a drug marketed by Sun Pharm Inds Ltd and is included in one NDA.
The generic ingredient in LORATADINE REDIDOSE is loratadine. There are thirty-nine drug master file entries for this compound. One hundred and fifty suppliers are listed for this compound. Additional details are available on the loratadine profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Loratadine Redidose
A generic version of LORATADINE REDIDOSE was approved as loratadine by PLD ACQUISITIONS LLC on January 21st, 2003.
Summary for LORATADINE REDIDOSE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 148 |
| Patent Applications: | 3,957 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | LORATADINE REDIDOSE at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for LORATADINE REDIDOSE
US Patents and Regulatory Information for LORATADINE REDIDOSE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharm Inds Ltd | LORATADINE REDIDOSE | loratadine | TABLET, ORALLY DISINTEGRATING;ORAL | 077153-001 | Apr 11, 2007 | OTC | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
